FJ Palella, KM Delaney, AC Moorman, MO … - New England Journal of Medicine, 1998 - content.nejm.org Results Mortality among the patients declined from 29.4 per 100 person-years in
1995 to 8.8 per 100 person-years in the second quarter of 1997. There were
reductions in mortality regardless of sex, race, age, and risk factors for ... Cited by 5744 - Related articles - BL Direct - All 9 versions
NG Pakker, DW Notermans, RJ De Boer, MTL … - Nature medicine, 1998 - nature.com The origin of CD4+ T cells reappearing in the blood following antiretroviral
therapy in human immunodeficiency virus type-1 (HIV-1) infection is still
controversial. Here we show, using mathematical modeling, that ... Cited by 553 - Related articles - BL Direct - All 6 versions
- ►annals.org [PDF] S Grabar, VL Moing, C Goujard, C Leport, MD … - Annals of internal medicine, 2000 - Am Coll Physicians Clinical Outcome of Patients with HIV-1 Infection according to ... Immunologic
and Virologic Response after 6 Months of Highly Active ... Sophie Grabar, MD,
MPH; Vincent Le Moing, MD, MPH; Cécile Goujard, MD; Catherine Leport, MD, ... Cited by 275 - Related articles - BL Direct - All 5 versions
- ►nejm.org GD Sanders, AM Bayoumi, V Sundaram, SP … - The New England Journal of Medicine (CME), 2005 - cme.nejm.org Results Given a 1 percent prevalence of unidentified HIV infection, screening
increased life expectancy by 5.48 days, or 4.70 quality-adjusted days, at an
estimated cost of $194 per screened patient, for a cost-effectiveness ratio ... Cited by 223 - Related articles - Cached - All 17 versions
JM Raboud, JS Montaner, B Conway, S Rae, P … - Aids, 1998 - pdfs.journals.lww.com Suppression of plasma viral load below 20 copies/ml is ... Janet M. Raboud,
Julio SG Montaner, Brian Conway, Sandra Rae, ... Peter Reiss*, Stephano Vella
† , David Cooper ‡ , Joep Lange § , ... Background: Current ... Cited by 209 - Related articles - BL Direct - All 8 versions
IC Marschner, AC Collier, RW Coombs, RT D' … - The Journal of infectious diseases, 1998 - UChicago Press Page 1. 40 Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type
1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy ... Cited by 182 - Related articles - BL Direct - All 4 versions
- ►pubget.com [PDF] R Paredes, A Mocroft, O Kirk, A Lazzarin, SE … - Archives of Internal Medicine, 2000 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Background Predictors of ... Cited by 172 - Related articles - BL Direct - All 5 versions
P Lorenzi, M Opravil, B Hirschel, JP Chave, HJ … - Aids, 1999 - journals.lww.com From the AIDS Centre, Geneva University Hospital, Geneva, the *Division of
Infectious Diseases, Zurich University Hospital, Zurich, † Ch. Porchat 24,
Lausanne, the ‡ AIDS Unit, University Hospital, Bern, the § Institute of ... Cited by 164 - Related articles - BL Direct - All 4 versions
C Piketty, P Castiel, L Belec, D Batisse, AS … - Aids, 1998 - journals.lww.com Piketty, Christophe; Castiel, Philippe; Belec, Laurent; Batisse, Dominique;
Mohamed, Ali Si; Gilquin, Jacques; Gonzalez-Canali, Gustavo; Jayle, Didier;
Karmochkine, Marina; Weiss, Laurence; Aboulker, Jean Pierre; Kazatchkine, ... Cited by 158 - Related articles - BL Direct - All 4 versions
EA Childs, RH Lyles, OA Selnes, B Chen, EN … - Neurology, 1999 - AAN Enterprises From the School of Hygiene and Public Health (EA Childs and Drs. Lyles, Chen,
and McArthur) and the School of Medicine (Drs. Selnes and McArthur), The Johns
Hopkins University, Baltimore, MD; UCLA Neuropsychiatric Institute (Dr. ... Cited by 138 - Related articles - BL Direct - All 3 versions
